These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

64 related items for PubMed ID: 2526527

  • 21. Effects of prostaglandin D2, 15-deoxy-Delta12,14-prostaglandin J2, and selective DP1 and DP2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats.
    Almishri W, Cossette C, Rokach J, Martin JG, Hamid Q, Powell WS.
    J Pharmacol Exp Ther; 2005 Apr; 313(1):64-9. PubMed ID: 15590767
    [Abstract] [Full Text] [Related]

  • 22. NADP-linked 15-hydroxyprostaglandin dehydrogenase for prostaglandin D in human blood platelets.
    Watanabe T, Shimizu T, Narumiya S, Hayaishi O.
    Arch Biochem Biophys; 1982 Jun; 216(1):372-9. PubMed ID: 6954879
    [No Abstract] [Full Text] [Related]

  • 23. Studies of cell adhesion and flow cytometric analyses of degranulation, surface phenotype, and viability using human eosinophils, basophils, and mast cells.
    Bochner BS, Sterbinsky SA, Saini SA, Columbo M, Macglashan DW.
    Methods; 1997 Sep; 13(1):61-8. PubMed ID: 9281469
    [Abstract] [Full Text] [Related]

  • 24. Mast cells and mast cell mediators in models of airway disease.
    Peters SP, Naclerio RM, Freeland HS, Togias A, Schleimer RP, MacGlashan DW, Kagey-Sobotka A, Fox CC, Adkinson NF, Lichtenstein LM.
    Prog Clin Biol Res; 1985 Sep; 199():153-61. PubMed ID: 2999818
    [No Abstract] [Full Text] [Related]

  • 25. Intranasal challenge with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients.
    Kowalski ML, Grzegorczyk J, Wojciechowska B, Poniatowska M.
    Clin Exp Allergy; 1996 Jul; 26(7):807-14. PubMed ID: 8842555
    [Abstract] [Full Text] [Related]

  • 26. Agonist and antagonist effects of 15R-prostaglandin (PG) D2 and 11-methylene-PGD2 on human eosinophils and basophils.
    Cossette C, Walsh SE, Kim S, Lee GJ, Lawson JA, Bellone S, Rokach J, Powell WS.
    J Pharmacol Exp Ther; 2007 Jan; 320(1):173-9. PubMed ID: 17041009
    [Abstract] [Full Text] [Related]

  • 27. Prostaglandin synthase 1 and prostaglandin synthase 2 both participate in activation-induced prostaglandin D2 production in mast cells.
    Kawata R, Reddy ST, Wolner B, Herschman HR.
    J Immunol; 1995 Jul 15; 155(2):818-25. PubMed ID: 7608559
    [Abstract] [Full Text] [Related]

  • 28. An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro.
    Sugimoto H, Shichijo M, Iino T, Manabe Y, Watanabe A, Shimazaki M, Gantner F, Bacon KB.
    J Pharmacol Exp Ther; 2003 Apr 15; 305(1):347-52. PubMed ID: 12649388
    [Abstract] [Full Text] [Related]

  • 29. Antagonists of the prostaglandin D2 receptor CRTH2.
    Pettipher R, Hansel TT.
    Drug News Perspect; 2008 Apr 15; 21(6):317-22. PubMed ID: 18836589
    [Abstract] [Full Text] [Related]

  • 30. Studies on the adhesive interaction between purified human eosinophils and cultured vascular endothelial cells.
    Lamas AM, Mulroney CM, Schleimer RP.
    J Immunol; 1988 Mar 01; 140(5):1500-5. PubMed ID: 3279115
    [Abstract] [Full Text] [Related]

  • 31. Generalized pruritus relieved by NSAIDs in the setting of mast cell activation syndrome.
    Kesterson K, Nahmias Z, Brestoff JR, Bodet ND, Kau A, Kim BS.
    J Allergy Clin Immunol Pract; 2018 Mar 01; 6(6):2130-2131. PubMed ID: 29577987
    [No Abstract] [Full Text] [Related]

  • 32. Monitoring mast cell activation by prostaglandin D2 in vivo.
    Dahlén SE, Kumlin M.
    Thorax; 2004 Jun 01; 59(6):453-5. PubMed ID: 15170020
    [No Abstract] [Full Text] [Related]

  • 33. Prostaglandin E2 increase in pachydermoperiostosis without 15-hydroprostaglandin dehydrogenase mutations.
    Nakahigashi K, Otsuka A, Doi H, Tanaka S, Okajima Y, Niizeki H, Hirakiyama A, Miyachi Y, Kabashima K.
    Acta Derm Venereol; 2013 Jan 01; 93(1):118-9. PubMed ID: 22735338
    [No Abstract] [Full Text] [Related]

  • 34. Eosinophilic cells as possible mast cell precursors.
    van den HOOFF.
    Nature; 1962 Apr 07; 194():97-8. PubMed ID: 13908745
    [No Abstract] [Full Text] [Related]

  • 35. [The role of mast cell in inflammation].
    Yamazaki A, Nakamura T, Omori K, Murata T.
    Nihon Yakurigaku Zasshi; 2017 Apr 07; 149(5):204-207. PubMed ID: 28484101
    [No Abstract] [Full Text] [Related]

  • 36. Prostaglandin modulation of mast cell-dependent inflammation.
    Raud J, Dahlén SE, Sydbom A, Lindbom L, Hedqvist P.
    Agents Actions; 1989 Jan 07; 26(1-2):42-4. PubMed ID: 2711948
    [No Abstract] [Full Text] [Related]

  • 37. PLA2G3 promotes mast cell maturation and function.
    Starkl P, Marichal T, Galli SJ.
    Nat Immunol; 2013 Jun 07; 14(6):527-9. PubMed ID: 23685814
    [Abstract] [Full Text] [Related]

  • 38. Mast Cells and Cellular Interactions, International Symposium. Berlin, September 15-16, 1995. Abstracts.
    J Invest Dermatol; 1995 Nov 07; 105(5):715-28. PubMed ID: 7594650
    [No Abstract] [Full Text] [Related]

  • 39. Human eosinophils: their accumulation, activation and fate.
    Walsh GM.
    Br J Haematol; 1997 Jun 07; 97(4):701-9. PubMed ID: 9217167
    [No Abstract] [Full Text] [Related]

  • 40. [Prostaglandin D2].
    Uehara Y.
    Nihon Rinsho; 1999 Nov 07; 57 Suppl():728-31. PubMed ID: 10635955
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.